Itau Unibanco Holding S.A. Sells 19,737 Shares of Lam Research Corporation $LRCX

Itau Unibanco Holding S.A. cut its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 93.2% in the second quarter, Holdings Channel reports. The firm owned 1,450 shares of the semiconductor company’s stock after selling 19,737 shares during the quarter. Itau Unibanco Holding S.A.’s holdings in Lam Research were worth $107,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in shares of Lam Research by 6.9% in the 1st quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company’s stock valued at $9,389,358,000 after acquiring an additional 8,364,375 shares during the last quarter. Nuveen LLC acquired a new position in Lam Research during the first quarter valued at approximately $604,344,000. Price T Rowe Associates Inc. MD grew its holdings in Lam Research by 99.7% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company’s stock valued at $417,242,000 after purchasing an additional 2,864,863 shares during the period. Nordea Investment Management AB increased its stake in Lam Research by 34.1% in the second quarter. Nordea Investment Management AB now owns 10,594,574 shares of the semiconductor company’s stock valued at $1,029,210,000 after purchasing an additional 2,692,189 shares in the last quarter. Finally, Boston Partners raised its holdings in Lam Research by 9,978.3% in the first quarter. Boston Partners now owns 2,350,362 shares of the semiconductor company’s stock worth $170,787,000 after purchasing an additional 2,327,041 shares during the period. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Trading Down 3.3%

NASDAQ:LRCX opened at $148.26 on Monday. The company has a market cap of $186.22 billion, a P/E ratio of 32.66, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $167.15. The business has a 50 day moving average price of $140.75 and a two-hundred day moving average price of $109.94. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the prior year, the business posted $0.86 EPS. The company’s quarterly revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. Lam Research’s payout ratio is 22.91%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on LRCX. Hsbc Global Res raised shares of Lam Research to a “hold” rating in a report on Tuesday, September 30th. Morgan Stanley boosted their target price on Lam Research from $125.00 to $137.00 and gave the company an “equal weight” rating in a research note on Thursday, October 23rd. Rothschild & Co Redburn increased their price target on Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Citigroup lifted their price objective on Lam Research from $175.00 to $190.00 and gave the company a “buy” rating in a report on Tuesday, November 11th. Finally, Mizuho boosted their price objective on Lam Research from $162.00 to $170.00 and gave the company an “outperform” rating in a research report on Thursday, October 23rd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $149.04.

Insider Transactions at Lam Research

In other news, insider Ava Harter sold 9,010 shares of the company’s stock in a transaction dated Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the sale, the insider directly owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. This represents a 13.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director owned 1,652 shares of the company’s stock, valued at $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 62,528 shares of company stock worth $8,880,448 in the last 90 days. Corporate insiders own 0.31% of the company’s stock.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.